The Sensitivity of Various Bacteria to Antibiotics During the Years 1951 to 1956

Giles, C. J.; Shuttleworth, Eileen M.

doi:10.1136/jcp.11.2.185

Cited by 7 publications

(2 citation statements)

References 11 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The advent of penicillin reduced the importance of such strains, and indeed seemed almost to banish the beta-haemolytic streptococcus from Britain for many years. A survey of the antibiotic sensitivities of pathogenic organisms isolated in a large English hospital from 1951 to 1956 does not mention the beta-haemolytic streptococcus, presumably because the numbers isolated were too small (Giles and Shuttleworth, 1958), and this was my experience during the same period in Eastern Scotland. From November 1957 to April 1959 1,002 strains were isolated in the laboratories of the Northern Ireland Hospital Authority Laboratory Service (Mitchell, 1962) land and Wales.…”

Section: Discussionmentioning

confidence: 99%

Beta-haemolytic streptococci in South-west Essex, with particular reference to tetracycline resistance.

Robertson¹

1965

BMJ

View full text Add to dashboard Cite

Section: Discussionmentioning

confidence: 99%

Beta-haemolytic streptococci in South-west Essex, with particular reference to tetracycline resistance.

Robertson¹

1965

BMJ

View full text Add to dashboard Cite

“…Before penicillin was commercially available, Dr Fleming raised awareness that bacteria could change after exposure to penicillin (Rosenblatt-Farrell, 2009). Surveillance/monitoring of in vitro activity of antimicrobials began in 1951 (Giles and Shuttleworth, 1958). Focus on antimicrobial activity in vitro has been intense, perhaps because it is the easiest to identify of the factors that contribute to clinical failure.…”

mentioning

confidence: 99%

Will antimicrobial resistance of BRD pathogens impact BRD management in the future?

Brumbaugh

2014

Anim. Health. Res. Rev.

View full text Add to dashboard Cite

Resistance is a qualitative interpretation of antimicrobial activity in vitro. Critical to management of bovine respiratory disease (BRD) is the clinical response in vivo. Attempts to connect activity in vitro to response in vivo have been complicated by the complexity of BRD, interpretation of antimicrobial activity in vitro, and inconsistent measures of clinical success or failure. During recent history, the discovery, development, and commercialization of antimicrobials have decreased. In response to resistance, voluntary and imposed restrictions on use of antimicrobials have been implemented. Resistance can be reversed using technology and knowledge of mechanisms of resistance. Perhaps approaches that reverse resistance will be used in clinical management of BRD in the future. The short answer to the question posed in the title is, 'yes.' Since antimicrobial drugs were discovered, resistance has been a consideration for selection of treatment of any infectious disease and BRD is not unique. In the opinion of the author, the more important question is, 'How will antimicrobial resistance of BRD pathogens impact BRD management in the future?'

show abstract

The Susceptibility of Staphylococci to Chloramphenicol

Fisher¹

1960

AMA Arch Intern Med

View full text Add to dashboard Cite

The Sensitivity of Various Bacteria to Antibiotics During the Years 1951 to 1956

Cited by 7 publications

References 11 publications

Beta-haemolytic streptococci in South-west Essex, with particular reference to tetracycline resistance.

Beta-haemolytic streptococci in South-west Essex, with particular reference to tetracycline resistance.

Will antimicrobial resistance of BRD pathogens impact BRD management in the future?

The Susceptibility of Staphylococci to Chloramphenicol

Contact Info

Product

Resources

About